Plasmapheresis therapy in combination with TNF-α inhibitor and DMARDs: A multitarget method for the treatment of rheumatoid arthritis

References

• Li R, Sun J, Ren LM, Wang HY, Liu WH, Zhang XW, et al. Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford). 2012;51:721–9.
   PubMed Web of Science ®Google Scholar
• Panayi GS. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis? Rheumatology (Oxford). 2005;44(Suppl2):ii3–7.
   PubMed Web of Science ®Google Scholar
• Molenaar ET, Voskuyl AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans BA. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum. 2004;50:36–42.
   PubMed Web of Science ®Google Scholar
• Hwang YG, Moreland LW. Induction therapy with combination TNF inhibitor and methotrexate in early rheumatoid arthritis. Curr Rheumatol Rep. 2014;16:417. doi: 10.1007/s11926-014-0417-8.
   PubMed Web of Science ®Google Scholar
• Nam JL, Villeneuve E, Hensor EM, Wakefield RJ, Conaghan PG, Green MJ, et al. A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial. Ann Rheum Dis. 2014;73:1027–36.
   PubMed Web of Science ®Google Scholar
• Decai Y, Xinchun Z, Guanghui W. Effect of leflunomide combined with methotrexate in treatment of rheumatoid arthritis. Clin J New Drugs Clin Rem. 2004;23:24–27.
   Google Scholar
• Allaart CF1, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Breedveld FC, Dijkmans BA. FARR study group. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study. Clin Exp Rheumatol. 2006;24(6Suppl43):S-77–82.
   Google Scholar
• van den Broek M, Dirven L, Klarenbeek NB, Molenaar TH, Han KH, Kerstens PJ, et al. The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study. Lancet. 2013;16381(9870):918–29.
   PubMed Web of Science ®Google Scholar
• Arnnet FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315.
   PubMed Web of Science ®Google Scholar
• Tan Q, Guo Q, Fang C, Wang C, Li B, Wang H, et al. Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products. MAbs. 2012;4(6):761–74.
   PubMed Web of Science ®Google Scholar
• Hassett B, McMillen S, Fitzpatrick B. Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products: letter to the editor. MAbs. 2013;5(5):624–5.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states [J]. Arthritis Rheum. 2005;52(9):2625–36.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Smolen JS. Remission of rheumatoid arthritis: should we care about definitions? Clin Exp Rheumatol.2006;24:S–51.
   Web of Science ®Google Scholar
• Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 1995;38:727–35.
   PubMed Web of Science ®Google Scholar
• Felson DT, Anderson JJ, Lange ML, Wells G, LaValley MP. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?. Arthritis Rheum. 1998;41:1564–70.
   PubMed Web of Science ®Google Scholar
• Pincus T, Sokka T, Kavanaugh A. Relative versus absolute goals of therapies for RA: ACR 20 or ACR 50 responses versus target values for near remission of DAS or single measures. Clin Exp Rheumatol. 2004;22(Suppl35):S50–6.
   PubMed Web of Science ®Google Scholar
• Stone JH. In: Klippel JH, Crofford LJ, eds. Primer on the rheumatic diseases. Atlanta, GA: Arthritis Foundation; 2001:209–32.
   Google Scholar
• Liu JD, Zhang C, Li WS Lun LD. Double filtration plasmapheresis for the treatment of rheumatoid arthritis: a study of 21 cases. Artif Organs. 1997;21:96–8.
   PubMed Web of Science ®Google Scholar
• Matsuda Y, Tsuda H, Takasaki Y, Hashimoto H. Double filtration plasmapheresis for the treatment of a rheumatoid arthritis patient with extremely high level of C-reaction protein. Ther Apher Dial. 2004;8:404–8.
   PubMed Web of Science ®Google Scholar
• McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis. 1998;57:350–6.
   PubMed Web of Science ®Google Scholar
• McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis. 1999;58:156–63.
   PubMed Web of Science ®Google Scholar
• Conaghan PG, O’Connor P, McGonagle D, Astin P, Wakefield RJ, Gibbon WW, et al. Elucidation of the relationship between synovitis and bone damage: A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum. 2003;48:64–71.
   PubMed Web of Science ®Google Scholar
• Sasso EH1, Merrill C, and Furst TE. Immunoglobulin binding properties of the Prosorba immunadsorption column in treatment of rheumatoid arthritis. Ther Apher. 2001;5(2):84–91.
   PubMedGoogle Scholar
• Kormelink TG, Tekstra J, Thurlings RM, Boumans MH, Vos K, Tak PP, et al. Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity. Ann Rheum Dis. 2010;69(12):2137–44.
   PubMed Web of Science ®Google Scholar
• Wolfe F. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum. 2000;43:2751–61.
   PubMed Web of Science ®Google Scholar
• Yu X, Ma J, Tian J, Jiang S, Xu P, Han H, Wang L. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis. J Clin Rheumatol. 2007;13(4):193–8.
   PubMed Web of Science ®Google Scholar
• Xuewu Z, Limin R, Yuan A. Immunoclearance in combination with immunosuppressive in treatment of refractory rheumatoid arthritis. Chin J Blood Purification. 2007;6(6):308–311.
   Google Scholar
• Furst D, Felson D, Thoren G, Gendreau RM. Immunoadsorption for the treatment of rheumatoid arthritis: final results of a randomized trial. Prosorba Trial Investigators. Ther Apher. 2000;4(5):363–73.
   PubMedGoogle Scholar
• Seror R, Pagnoux C Guillevin L. Plasma exchange for rheumatoid arthritis. Transfus Apher Sci. 2007;36(2):195–9.
   PubMed Web of Science ®Google Scholar
• Wang BC, Hsu PN, Furnback W, Ney J, Yang YW, Fang CH, Tang CH. estimating the economic burden of rheumatoid arthritis in Taiwan using the National Health Insurance Database. Drugs Real World Outcomes. 2016;3:107–14.
   PubMedGoogle Scholar
• Singh JA. Editorial: arthroplasty outcomes are improving, but why isn't my patient with rheumatoid arthritisdoing as well? Arthritis Rheumatol. 2014;66(2):250–3.
   Web of Science ®Google Scholar
• Smolen JS, Nash P, Durez P, Hall S, Ilivanova E, Irazoque-Palazuelos F, et al. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial. Ann Rheum Dis. 2012;71(2):245–8.
   PubMed Web of Science ®Google Scholar
• Contreras-Yáñez I, Pascual-Ramos V. Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters. Arthritis Res Ther. 2015;1117:177. doi: 10.1186/s13075-015-0697-z.
   PubMed Web of Science ®Google Scholar
• Raza K, Filer A. The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?. Ann Rheum Dis. 2015; 74(5):793–4.
   PubMed Web of Science ®Google Scholar